Device type · CAF
Nebulizer (Direct Patient Interface)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CAF
Anesthesiology
Device class
Class II
FDA decisions since 2015
72
510(k), De Novo and PMA
Adverse event reports
727
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Nebulizer (Direct Patient Interface)
- Product code
- CAF
- Device class
- Class II
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.5630
- Specialty
- Anesthesiology & Respiratory, Pulmonology
- FDA record
- Classification database entry for CAF
Latest FDA decisions
The 8 newest of 72 since 2015.
- Mesh Nebulizer (UN204); Mesh Nebulizer (UN205); Mesh Nebulizer (UN209); Mesh Nebulizer (UN210)510(k)
Shenzhen Mericonn Technology Co., Ltd.
K254171 · Decided Sep 18, 2026 · 269 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
K260270 · Decided Jun 2, 2026 · 125 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
Pari Respiratory Equipment, Inc.
K251572 · Decided Dec 19, 2025 · 211 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
- Mesh Nebulizer (H6)510(k)
Qingdao Future Medical Technology Co., Ltd.
K251659 · Decided Nov 14, 2025 · 168 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
Shenzhen Jermei Medical Device Technology Co., Ltd.
K244035 · Decided Sep 19, 2025 · 263 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
K243468 · Decided Jul 2, 2025 · 236 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
- HeroTracker Sense510(k)
K250022 · Decided Jun 30, 2025 · 178 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
K250583 · Decided Jun 20, 2025 · 113 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
Reports received
727
Received Nov 1, 2025 to Nov 19, 2026. Includes 46 of another or unstated type.
Malfunction reports
653
90% of reports
Injury reports
23
3.2% of reports
Death reports
5
0.7% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 9 | 0 | 1 | 0 |
| Jan 24 | 5 | 3 | 0 | 1 |
| Feb 24 | 3 | 0 | 0 | 0 |
| Mar 24 | 9 | 0 | 0 | 0 |
| Apr 24 | 1 | 6 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 6 | 2 | 0 | 0 |
| Jul 24 | 3 | 1 | 2 | 0 |
| Aug 24 | 3 | 0 | 0 | 0 |
| Sep 24 | 3 | 0 | 0 | 1 |
| Oct 24 | 24 | 1 | 0 | 0 |
| Nov 24 | 12 | 1 | 1 | 0 |
| Dec 24 | 8 | 4 | 0 | 0 |
| Jan 25 | 9 | 2 | 6 | 1 |
| Feb 25 | 12 | 1 | 1 | 0 |
| Mar 25 | 11 | 3 | 1 | 0 |
| Apr 25 | 13 | 6 | 1 | 0 |
| May 25 | 8 | 3 | 0 | 0 |
| Jun 25 | 9 | 1 | 2 | 0 |
| Jul 25 | 8 | 0 | 1 | 0 |
| Aug 25 | 4 | 3 | 0 | 0 |
| Sep 25 | 16 | 4 | 1 | 0 |
| Oct 25 | 33 | 9 | 0 | 2 |
| Nov 25 | 12 | 1 | 1 | 0 |
| Dec 25 | 7 | 1 | 1 | 0 |
| Jan 26 | 11 | 2 | 1 | 0 |
| Feb 26 | 10 | 1 | 1 | 0 |
| Mar 26 | 13 | 1 | 1 | 0 |
| Apr 26 | 20 | 2 | 0 | 0 |
| May 26 | 68 | 0 | 0 | 1 |
| Jun 26 | 36 | 4 | 0 | 0 |
| Jul 26 | 21 | 2 | 0 | 3 |
| Aug 26 | 266 | 7 | 0 | 12 |
| Sep 26 | 119 | 2 | 0 | 15 |
| Oct 26 | 70 | 0 | 0 | 15 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Unk6
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Infusion or Flow Problem76
- Break55
- No Flow50
- Fluid/Blood Leak39
- Restricted Flow rate39
- Pressure Problem36
- Fitting Problem31
- Insufficient Heating28
- Detachment of Device or Device Component26
- Crack25
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions636
- Insufficient Information65
- Low Oxygen Saturation8
- Unspecified Respiratory Problem7
- Bronchospasm6
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available4
- Dyspnea3
- Pneumonia3
- Chronic Obstructive Pulmonary Disease (COPD)1
- Decreased Respiratory Rate1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- HUDSON RCI Addipak, UNIT DOSE VIALS, 5mL Sterile 0.9% NaCl Solution for Inhalation USP. REF RHUD59UOpen, Classified
MEDLINE INDUSTRIES, LP - Northfield
Z-2514-2023 · Started Aug 4, 2023 · Posted by FDA Sep 14, 2023
Reason given: Product dispositioned for scrap for sterility failure investigation that was inadvertently shipped to customers.
Cause as FDA categorized it: Process control
Z-1516-2021 · Started Mar 31, 2021
Reason given: The firm became aware via complaints that one lot of ACE MDI Spacers with Small Masks and one lot of Palm Cups (Large) may have incorrect shipping box labels.
Cause as FDA categorized it: Process control
Z-1058-2019 · Started Aug 29, 2018
Reason given: The product was designed for 120V usage and is being used in South Africa with 220V. There is a potential for the device to overheat and the mouthpiece can pop off.
Cause as FDA categorized it: Device Design
Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Z-0710-2019 · Started Sep 5, 2017 · Posted by FDA Feb 4, 2019
Reason given: Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
Cause as FDA categorized it: Process control
Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Z-0711-2019 · Started Sep 5, 2017 · Posted by FDA Feb 4, 2019
Reason given: Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
Cause as FDA categorized it: Process control
Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Z-0712-2019 · Started Sep 5, 2017 · Posted by FDA Feb 4, 2019
Reason given: Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
Cause as FDA categorized it: Process control
Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Z-0713-2019 · Started Sep 5, 2017 · Posted by FDA Feb 4, 2019
Reason given: Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
Cause as FDA categorized it: Process control
Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Z-0714-2019 · Started Sep 5, 2017 · Posted by FDA Feb 4, 2019
Reason given: Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
Cause as FDA categorized it: Process control
Showing the 8 newest of 36 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.